HCA Healthcare Shares Dip 0.55 as Volume Ranks 226th Amid Mixed Institutional Moves and Analyst Outlooks

HCA Healthcare (HCA) closed on August 18, 2025, with a 0.55% decline, trading at $395.83 per share. The stock recorded a daily trading volume of $0.4 billion, ranking 226th in market activity. Recent institutional activity included Aberdeen Group reducing its stake by 4.3%, now holding $71.61 million worth of shares, while the State of New Jersey Common Pension Fund D cut its position by 11.4%, retaining $21.9 million in holdings. Other investors, including Goldman Sachs and Pacer Advisors, significantly increased their stakes, reflecting mixed institutional sentiment.

The company reported Q2 earnings of $6.84 per share, exceeding estimates by $0.64, with revenue rising 6.4% year-over-year to $18.61 billion. Analysts remain divided, with Wolfe Research downgrading HCA from “outperform” to “peer perform,” while JPMorgan raised its price target to $370.00. The stock maintains a “Moderate Buy” consensus rating, with an average price target of $398.58. HCA also announced a quarterly dividend of $0.72 per share, yielding 0.7%, signaling continued shareholder returns amid operational growth.

A backtested strategy of buying the top 500 stocks by daily trading volume and holding them for one day yielded a 23.4% cumulative return from 2022 to the present, generating $2,340 in profit. While positive, the result underscores the conservative nature of volume-based trading approaches in the current market environment.